The purpose of this study is to investigate pancreatic cancer. It is a multi-center observational study conducted in China.
This study evaluates the safety and effectiveness of an investigational medication in real-world settings.
- Who can participate: Adults aged 18 and older with pancreatic ductal adenocarcinoma who are undergoing treatment with the investigational medication can participate.
- Study details: The study will collect data on treatment patterns and outcomes.